Innovations in Biosensor Technologies for Healthcare Diagnostics and Therapeutic Drug Monitoring: Applications, Recent Progress, and Future Research Challenges
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
This comprehensive review delves into the forefront of biosensor technologies and their critical roles in disease biomarker detection and therapeutic drug monitoring. It provides an in-depth analysis of various biosensor types and applications, including enzymatic sensors, immunosensors, and DNA sensors, elucidating their mechanisms and specific healthcare applications. The review highlights recent innovations such as integrating nanotechnology, developing wearable devices, and trends in miniaturisation, showcasing their transformative potential in healthcare. In addition, it addresses significant sensitivity, specificity, reproducibility, and data security challenges, proposing strategic solutions to overcome these obstacles. It is envisaged that it will inform strategic decision-making, drive technological innovation, and enhance global healthcare outcomes by synthesising multidisciplinary insights.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Doxorubicin: The good, the bad and the ugly effect
Carvalho, C., Santos, R., Cardoso, S., Correia, S., Oliveira, P., Santos, M., & Moreira, P. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709788803312 · Cited by 1,509 · cited 1×
“Therefore, optimising the dose administered to cancer patients and monitoring it is vital in doxorubicin therapy [173].”
BackgroundIrinotecan: mechanisms of tumor resistance and novel strategies for modulating its activity.
Xu, Y., & Villalona-Calero, M. A. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf337 · Cited by 413
Artificial intelligence biosensors: Challenges and prospects
Jin, X., Liu, C., Xu, T., Su, L., & Zhang, X. (2020) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2020.112412 · Cited by 399
Optical biosensors: A decade in review
Singh, A. K., Mittal, S., Das, M., Saharia, A., & Tiwari, M. (2023) · Alexandria Engineering Journal · doi:10.1016/j.aej.2022.12.040 · Cited by 292 · cited 1×
“Electronics emerge as a critical component tasked with amplifying and processing signals generated by the transducer, often characterised by their initial weakness, necessitating enhancement for meaningful interpretation [48,49].”
BackgroundPullano, S. A., Greco, M., Bianco, M. G., Foti, D., Brunetti, A., & Fiorillo, A. S. (2022) · Theranostics · doi:10.7150/thno.64035 · Cited by 210 · cited 1×
“This ongoing monitoring enables people to make informed choices regarding insulin doses and lifestyle changes instantly [123].”
BackgroundFlexible Plasmonic Biosensors for Healthcare Monitoring: Progress and Prospects
Song, L., Chen, J., Xu, B. B., & Huang, Y. (2021) · ACS Nano · doi:10.1021/acsnano.1c07176 · Cited by 186
Ngoepe, M., Choonara, Y., Tyagi, C., Tomar, L., Du Toit, L., Kumar, P., Ndesendo, V., & Pillay, V. (2013) · Sensors · doi:10.3390/s130607680 · Cited by 92 · cited 2×
“…This revolution has facilitated prompt interventions, personalised treatment plans, and enhanced patient outcomes [20–24]. ef ‐ patient outcomes [20 Emerging developments like wearable biosensors, point-of-care testing tools, implantable devices, telemedicine applications, and remote monitoring…”
Background
Metadata
- Authors
- Hemdan, M., Ali, M. A., Doghish, A. S., Mageed, S. S. A., Elazab, I. M., Khalil, M. M., Mabrouk, M., Das, D. B., & Amin, A. S.
- Venue
- Sensors
- Publisher
- MDPI AG
- Published
- 2024-08-08
- Volume
- 24
- Issue
- 16
- Pages
- 5143
- ISSN
- 1424-8220 (ISSN-L)
- OpenAlex
- W4401459206
- Cited by
- 240
- References
- 7
- FWCI
- 24.76
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Innovations in Biosensor Technologies for Healthcare Diagnostics and Therapeutic Drug Monitoring: Applications, Recent Progress, and Future Research Challenges. https://app.cochat.ai/papers/10.3390/s24165143
- The paper
- Hemdan, M., Ali, M. A., Doghish, A. S., Mageed, S. S. A., Elazab, I. M., Khalil, M. M., Mabrouk, M., Das, D. B., & Amin, A. S. (2024). Innovations in Biosensor Technologies for Healthcare Diagnostics and Therapeutic Drug Monitoring: Applications, Recent Progress, and Future Research Challenges. Sensors. https://doi.org/10.3390/s24165143
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.